Reaction: Meloxicam to 1 product
- Reaction
- Reaction type
- Not Available
- Direction
- Not Available
- Major circulating metabolite?
- No
- Spontaneous?
- No
- Activity
- unknown
- References
- Prasad GS, Srisailam K, Sashidhar RB: Metabolic inhibition of meloxicam by specific CYP2C9 inhibitors in Cunninghamella blakesleeana NCIM 687: in silico and in vitro studies. Springerplus. 2016 Feb 24;5:166. doi: 10.1186/s40064-016-1794-4. eCollection 2016. [Article]
- FDA approved products: Mobic (meloxicam) oral tablets [Link]
- Comments
- The bacteria Cunninghamella blakesleeana is reported to be involved in the biotransformation of meloxicam.
- Enzymes
- Not Available